By improving insulin sensitivity and reducing compensatory hyperinsulinaemia, these medications may help address the hormonal imbalances that drive androgen excess
Researchers are investigating genetic variants in GLP-1 receptor pathways, gut microbiome profiles, and baseline hormone levels to determine who will respond best to GLP-1 therapy, who might benefit from dual agonists, and who is more prone to side effects
Diabetes Research and GLP-1 Active GLP-1 is highly conserved across mammalian species, allowing investigators to study the hormone across different model organisms such as rodents and humans for over 20 years 2,10,15
During clinical trials, adults taking Wegovy lost an average of nearly 15 percent of their starting body weight
Its versatility covers numerous research areas, including obesity, metabolic syndrome, diabetes, and cardiovascular health
Long-term safety data still pending